The clinical performance of this innovative device was studied in hospital and school settings.
The new research indicating a time-dependent result for COVID-19 testing may have significant implications for the clinical laboratories.
In a new first, molecular testing for COVID-19 can now be performed at home without a prescription, changing the COVID-19 testing market.
This alert identifies two issues and issues three recommendations.
Use of this technology could be preventive, administered to people before they have an infection, says Rensselaer professor.
Centers for Medicare and Medicaid Services (CMS) makes at least eight key points about commercial payer coverage related to COVID-19 testing and vaccination.
A sustained drop in COVID-19 diagnostic testing could present the clinical laboratory industry with opportunities, but it could also lead to potential damages if not handled proactively and correctly.
Now available for streaming: How does your lab begin to prepare itself to succeed in a post-pandemic world? Start your plan now to navigate the transition. Attend this complimentary webinar and hear the ways in which your lab’s current testing can create assets for the future, and how you can best position your lab for success in a post-pandemic environment by leveraging your diagnostic data as a strategic asset.
While T-cell immunity is still a very active field of COVID-19 study, this new test now allows clinicians to offer T-cell COVID-19 testing for their patients.
FDA Changes Storage Requirements for Pfizer COVID-19 Vaccine, Facilitating Faster and More Widespread Use
New storage requirement for Pfizer vaccine makes it easier for clinical laboratory personnel to access vaccine.